Okada Takashi, Washida Kazuo, Irie Kenichi, Saito Satoshi, Noguchi Michio, Tomita Tsutomu, Koga Masatoshi, Toyoda Kazunori, Okazaki Shuhei, Koizumi Takashi, Mizuta Ikuko, Mizuno Toshiki, Ihara Masafumi
Department of Neurology, National Cerebral and Cardiovascular Center, Osaka, Japan.
Research Fellow of Japan Society for the Promotion of Science, Tokyo, Japan.
Front Aging Neurosci. 2020 May 14;12:130. doi: 10.3389/fnagi.2020.00130. eCollection 2020.
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common hereditary small vessel disease, with reported frequencies of 2-5/100,000 individuals. Recently, it has been reported that some patients with gene mutations show atypical clinical symptoms of CADASIL. Assuming that CADASIL is underdiagnosed in some cases of lacunar infarction, this study was designed to examine the prevalence of gene mutations in the patients at highest risk who were admitted for lacunar infarctions. From January 2011 to April 2018, 1,094 patients with lacunar infarctions were admitted to our hospital, of whom 31 patients without hypertension but with white matter disease (Fazekas scale 2 or 3) were selected and genetically analyzed for gene mutations (Phase 1). Furthermore, 54 patients, who were 60 years or younger, were analyzed for mutations (Phase 2). exons 2-24, which encode the epidermal growth factor-like repeat domain of the receptor, were analyzed for mutations by direct sequencing of genomic DNA. Three patients presented p.R75P mutations: two in the Phase 1 and one in the Phase 2 cohort. Among patients aged 60 years or younger and those without hypertension but with moderate-to-severe white matter lesions, the carrier frequency of p.R75P was 3.5% (3/85), which was significantly higher than that in the Japanese general population (4.7KJPN) (odds ratio [95% CI] = 58.2 [11.6-292.5]). All three patients with mutations had family histories of stroke, and the average patient age was 51.3 years. All three patients also showed white matter lesions in the external capsule but not in the temporal pole. The CADASIL and CADASIL scale-J scores of the three patients were 6, 17, 7 (mean, 10.0) and 13, 20, 10 (mean, 14.3), respectively. Among patients hospitalized for lacunar infarctions, the p.R75P prevalence may be higher than previously estimated. The p.R75P mutation may be underdiagnosed in patients with early-onset lacunar infarctions due to the atypical clinical and neuroimaging features of CADASIL. Early-onset, presence of family history of stroke, external capsule lesions, and absence of hypertension may help predict underlying mutations despite no temporal white matter lesions.
伴有皮质下梗死和白质脑病的常染色体显性遗传性脑动脉病(CADASIL)是最常见的遗传性小血管病,据报道发病率为2 - 5/100,000人。最近,有报道称一些有该基因突变的患者表现出CADASIL的非典型临床症状。假设CADASIL在某些腔隙性脑梗死病例中未被充分诊断,本研究旨在调查因腔隙性脑梗死入院的高危患者中该基因突变的患病率。2011年1月至2018年4月,1094例腔隙性脑梗死患者入住我院,其中31例无高血压但有白质病变(Fazekas分级为2或3级)的患者被选入并进行该基因突变的基因分析(第一阶段)。此外,对54例60岁及以下的患者进行该基因突变分析(第二阶段)。通过对基因组DNA进行直接测序,分析编码该受体表皮生长因子样重复结构域的外显子2 - 24中的突变情况。3例患者出现p.R75P突变:2例在第一阶段队列中,1例在第二阶段队列中。在60岁及以下且无高血压但有中度至重度白质病变的患者中,p.R75P的携带频率为3.5%(3/85),显著高于日本普通人群(4.7KJPN)(优势比[95%置信区间]=58.2[11.6 - 292.5])。所有3例有该基因突变的患者都有中风家族史,患者平均年龄为51.3岁。所有3例患者在壳核均有白质病变,但颞极无病变。这3例患者的CADASIL和CADASIL量表-J评分分别为6、17、7(平均10.0)和13、20、10(平均14.3)。在因腔隙性脑梗死住院的患者中,p.R75P的患病率可能高于先前估计。由于CADASIL非典型的临床和神经影像学特征,p.R75P突变在早发性腔隙性脑梗死患者中可能未被充分诊断。早发性、有中风家族史、壳核病变以及无高血压可能有助于预测潜在的该基因突变,尽管没有颞叶白质病变。